Molecular Partners AG (MOLN) Financials

NASDAQ Currency in USD Disclaimer

$5.31

north_east $0.01 (0.19%)
Day's range
$5.31
Day's range
$5.31

MOLN Income statement / Annual

Last year (2023), Molecular Partners AG's total revenue was $7.04 M, a decrease of 96.29% from the previous year. In 2023, Molecular Partners AG's net income was -$61.98 M. See Molecular Partners AG�s key income statements, including revenue, expenses, profit, and income.

Period FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016 FY-2015 FY-2014
Period Ended 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Operating Revenue $7.04 M $189.56 M $9.33 M $9.34 M $20.38 M $10.36 M $20.02 M $23.04 M $29.12 M $26.63 M
Cost of Revenue $47.84 M $50.75 M $55.72 M $56.08 M $43.50 M $15.60 M $17.82 M $14.57 M $1.17 M $170,750.00
Gross Profit -$40.81 M $138.81 M -$46.39 M -$46.73 M -$23.12 M -$5.25 M $2.19 M $8.47 M $27.95 M $26.45 M
Gross Profit Ratio -5.8 0.73 -4.97 -5 -1.13 -0.51 0.11 0.37 0.96 0.99
Research and Development Expenses $48.78 M $50.75 M $55.72 M $56.08 M $43.50 M $38.20 M $37.45 M $35.19 M $23.92 M $18.79 M
General & Administrative Expenses $19.00 M $21.82 M $16.91 M $11.03 M $13.16 M $9.46 M $8.28 M $7.24 M $6.22 M $4.90 M
Selling & Marketing Expenses $0.00 $0.00 $0.00 $57,000.00 $5.23 M $0.00 $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $19.00 M $21.82 M $16.91 M $11.03 M $13.16 M $9.46 M $8.28 M $7.24 M $6.22 M $4.90 M
Other Expenses -$47.48 M $372,000.00 $125,000.00 $568,000.00 $381,000.00 -$9.76 M -$12.12 M -$9.38 M $4.16 M $4.29 M
Operating Expenses $20.30 M $72.94 M $72.75 M $67.67 M $57.04 M $47.77 M $45.86 M $42.53 M $31.34 M $24.78 M
Cost And Expenses $68.15 M $72.94 M $72.75 M $67.67 M $57.04 M $47.77 M $45.86 M $42.53 M $31.34 M $24.78 M
Interest Income $4.28 M $1.14 M $99,000.00 $367,000.00 $1.60 M $693,000.00 $610,000.00 $335,000.00 $357,517.00 $347,846.00
Interest Expense $49,000.00 $605,000.00 $548,000.00 $271,000.00 $27,000.00 $591,000.00 $197,000.00 $89,000.00 $216.00 $853.00
Depreciation & Amortization $2.42 M $2.39 M $2.57 M $2.89 M $2.47 M $924,000.00 $1.15 M $1.09 M $909,386.00 $809,532.00
EBITDA -$59.53 M $120.85 M -$60.85 M -$59.59 M -$33.71 M -$36.27 M -$24.70 M -$18.06 M -$1.02 M -$1.47 M
EBITDA Ratio -8.46 0.63 -6.51 -5.9 -1.6 -3.5 -1.2 -0.78 -0.04 0.11
Operating Income Ratio -8.68 0.62 -6.8 -6.24 -1.8 -3.61 -1.29 -0.85 -0.08 0.07
Total Other Income/Expenses Net -$876,000.00 $1.24 M -$365,000.00 -$4.45 M $389,000.00 $374,000.00 $414,000.00 $874,000.00 $2.07 M -$4.12 M
Income Before Tax -$61.98 M $117.85 M -$63.78 M -$62.78 M -$36.27 M -$37.04 M -$25.43 M -$18.61 M -$148,823.00 -$2.28 M
Income Before Tax Ratio -8.81 0.62 -6.84 -6.72 -1.78 -3.58 -1.27 -0.81 -0.01 -0.09
Income Tax Expense $0.00 -$1.24 M $2,000.00 -$11,000.00 $17,000.00 -$591,000.00 -$414,000.00 -$874,000.00 -$2.07 M $4.12 M
Net Income -$61.98 M $117.85 M -$63.79 M -$62.76 M -$36.29 M -$37.04 M -$25.43 M -$18.61 M -$148,823.00 -$2.28 M
Net Income Ratio -8.81 0.62 -6.84 -6.72 -1.78 -3.58 -1.27 -0.81 -0.01 -0.09
EPS -1.89 3.63 -2.06 -2.51 -1.69 -1.75 -1.22 -0.91 -0.0076 -0.15
EPS Diluted -1.89 3.54 -2.06 -2.51 -1.69 -1.75 -1.22 -0.91 -0.0076 -0.15
Weighted Average Shares Out $32.77 M $32.47 M $31.01 M $25.00 M $21.41 M $21.17 M $20.86 M $20.43 M $19.54 M $15.22 M
Weighted Average Shares Out Diluted $32.77 M $33.27 M $31.01 M $25.00 M $21.41 M $21.17 M $20.86 M $20.43 M $19.54 M $15.29 M
Link